Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 23.77
- Piotroski Score 3.00
- Grade Buy
- Symbol (NTRB)
- Company Nutriband Inc.
- Price $5.01
- Changes Percentage (1.42%)
- Change $0.07
- Day Low $4.75
- Day High $5.04
- Year High $9.60
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. Nutriband Inc. has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. The company was incorporated in 2016 and is headquartered in Orlando, Florida.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 12/09/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.77
- Trailing P/E Ratio -6.75
- Forward P/E Ratio -6.75
- P/E Growth -6.75
- Net Income $-5,485,314
Income Statement
Quarterly
Annual
Latest News of NTRB
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Nutriband (NASDAQ:NTRB investor five-year losses grow to 80% as the stock sheds US$27m this past week
Nutriband Inc. (NASDAQ:NTRB) share price has surged 72% in the last quarter, but has dropped 80% over the last five years. Despite strong revenue growth, the company's profitability remains a concern....
By Yahoo! Finance | 3 months ago
